Yuzhu Zhang Yuchen Liu Jing Liu Tiande Liu Hu Xiong Wen Li Xiaowei Fu Fan Zhou Shousheng Liao Lu Fang Bo Liang
10.3389/fimmu.2023.1144371
Front Immunol
2023 Mar 20;14:1144371.
gbc pd-l1 s-1 immunotharapy tislelizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/37020545/
Bile Duct Neoplasms / drug therapy Cholangiocarcinoma / drug therapy Gallbladder Neoplasms / drug therapy
Bile Duct Neoplasms / drug therapy Cholangiocarcinoma / drug therapy Gallbladder Neoplasms / drug therapy Review Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized / therapeutic use B7-H1 Antigen Bile Ducts, Intrahepatic Humans tislelizumab B7-H1 Antigen Antibodies, Monoclonal, Humanized
PMC10067585
37020545
Case report: Preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: A report of five cases and a literature review
2023